Financing boosts bioscience firm with $24M raise
Kiora Pharmaceuticals raised up to $24M via private placement, providing a cash runway into late 2028 while advancing clinical trials for a retinal disease therapy.
View filing at SEC.gov →2 most recent filings and news items mentioning KPRX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/KPRX/news?limit=20"
Pull KPRX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayKiora Pharmaceuticals raised up to $24M via private placement, providing a cash runway into late 2028 while advancing clinical trials for a retinal disease therapy.
View filing at SEC.gov →Kiora Pharmaceuticals announced preclinical data showing KIO-300 significantly reduced seizure-associated activity in a temporal lobe epilepsy model, suggesting therapeutic potential beyond its current ophthalmology focus. The findings could expand the company's ion channel modul
View filing at SEC.gov →